Dec. 14, 2023. (AP Photo/Andrew Harnik, File) WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be ...
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...